HYLA™ Blood
Monitoring System
Free from cuvettes. Seamless Shifts Across Procedures.
HYLA™ Simplifies Workflows, Reduces Risks
While Delivering Real-Time High Accuracy
Cuvette-Free
ONE SENSOR FITS ALL
Fits all perfusion systems and tubing sizes with a single standardized sensor.
SEAMLESS TRANSITIONS
Enables smooth shifts between procedures and circuits with no added overhead.
ACCURACY IN REAL TIME
Provides instant inline measurements, giving clinicians reliable data to support confident, timely decisions.
AUXILIARY FLOW MONITORING
Supports up to two flow probes for monitoring auxiliary circuits (e.g. cerebral perfusion) without interrupting main flow measurements.
OPERATIONAL EFFICIENCY
Reduces complexity, lowers consumables use, and eases procurement and inventory management.
HYLA™ SYSTEM
Built for Clinical Versatility.
Comprehensive Monitoring in a single, robust platform
Supports simultaneous connection of blood sensors for arterial and venous lines.
Two integrated flow sensors enable Goal-Directed Perfusion (GDP) strategies.
Two integrated flow sensors enable Goal-Directed Perfusion (GDP) strategies.
Compact & Unobtrusive
Delivers continuous data without obstructing the workspace - lightweight, easy to position,
and designed to keep the surgical field view clear.
and designed to keep the surgical field view clear.
HYLA™ Specifications
| Category | Details |
|---|---|
| Supported Sensors | Two HYLA sensors and two flow sensors |
| Measurements | SO₂, Hematocrit/Hemoglobin, Flow *pO₂, pCO₂, pH |
| Calculated Parameters | Goal-Directed Perfusion indexes (DO₂i, VO₂i) |
| Tubing Compatibility | 1/2" x 3/32", 3/8" x 3/32", 1/4" x 3/32" |
| Connectivity | EMR-ready |
| Power | AC/DC charger, internal backup battery |
| Touchscreen Display | Customizable views and alerts, easy alignment with blood gas analyzer |
*Next version parameters
Disclaimer: HYLA™ has not been cleared or approved by the FDA
or any other regulatory authority. Availability is subject to future
regulatory authorization.
or any other regulatory authority. Availability is subject to future
regulatory authorization.
